Hogan Lovells Publications
Podcast: Talking the cure
15 April 2021
PartnerBrussels
Email fabien.roy@hoganlovells.com
Phone +32 2 505 0970
Fax +32 2 505 0996
LanguagesEnglish, French
Practice groupGlobal Regulatory
'Particularly knowledgeable about EU regulatory issues concerning medical devices'
Legal 500 Belgium Life Sciences 2017
As partner of our Life Sciences practice, Fabien Roy focuses his practice at Hogan Lovells on advising clients on European Union (EU) and national regulatory matters involving medical devices and pharmaceutical laws and guidelines. Fabien follows the new regulations on medical devices (MDR and IVDR) and the GDPR very closely and regularly advises clients on the requirements applicable to their digital health technologies. With a practice entirely focusing on complex regulatory issues faced by Life Sciences clients, he can quickly address and anticipate complex challenges and propose innovative solutions enabling clients to focus on their business.
Fabien focuses particularly on guiding clients through the regulatory and technical regulatory requirements applicable to the CE marking of medical devices. He assists clients in addressing a range of complex issues during clinical investigation procedures (e.g. authorisation from the EU Member States competent authorities, opinion from Ethics Committee, amendment to the Protocol, informed consent, serious adverse event qualification and notification, handling of personal data), conformity assessment and registration procedures (e.g. preparation and review of Technical Files, preparation and review of responses to the competent authorities' and Notified Bodies' requests) and post-market activities (e.g. adverse event reporting, Field Safety Corrective Actions and promotional and advertising of medical devices).
Fabien is also a qualified lead auditor for ISO 13485 quality management systems. He consequently has a deep understanding of the range of quality issues encountered by medical device Clients. Fabien also assists Life Sciences Clients in the preparation, drafting and review of numerous agreements including clinical study agreements, sponsor's representative agreements, registry agreements, CRO agreements, European Authorised Representative Agreements and distribution agreements.
EU Regulatory: Pharma, Medical Devices and Biotech, Next Generation Partner
Legal 500 EMEA
EU Regulatory: Pharma, Medical Devices and Biotech
Legal 500 EMEA
Rising Star, Life Sciences, Belgium
Expert Guides
Brussels Life Sciences practices awarded Finance Monthly – Law Award 2015 in the category of Life Sciences Law Firm of the Year – Belgium
Education
D.E.S.S. European Law, Université de Rennes 1, with merit, 2007
Memberships
the European Forum for Good Clinical Practice (EFGCP)-MedTech Europe Working Party
Qualified Lead Auditor ISO 13485
Qualified Lead Auditor ISO 13485
Bar admissions and qualifications
Brussels
Hogan Lovells Publications
15 April 2021
Hogan Lovells Publications
23 February 2021
News
19 January 2021
News
13 January 2021
Hogan Lovells Publications
2020
News
08 December 2020